Fig. 4

Evaluation of concomitant drugs. (a-b) Bliss scores calculated after treatment with concomitant drugs at 10 µM for 72 h in HCT116-GFP (a) and A549-NLR (b). Data shown as mean ± SEM from three independent experiments. (c-d) Viability in HCT116-GFP (c) and A549-NLR (d) monocultures treated with concomitant drugs for 72 h. Data shown as mean ± SEM from three independent experiments. (e-f) Bliss scores (x-axis) plotted against the viability in PBMC monocultures (y-axis) after treatment with concomitant drugs at 10 µM for 72 h in HCT116-GFP (e) and A549-NLR (f). Data shown as means from three independent experiments